Captopril improves postresuscitation hemodynamics protective against pulmonary embolism by activating the ACE2/Ang-(1-7)/Mas axis
暂无分享,去创建一个
Lianxing Zhao | Chun-Sheng Li | Jun Yang | Nan Tong | Hong-li Xiao | L. An | Qi-Tong Liu | Chun-Sheng Li | Le An
[1] Yingchuan Li,et al. Angiotensin-Converting Enzyme Inhibition Attenuates Lipopolysaccharide-Induced Lung Injury by Regulating the Balance Between Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 and Inhibiting Mitogen-Activated Protein Kinase Activation , 2015, Shock.
[2] L. Luo,et al. Activation of renin–angiotensin–aldosterone system (RAAS) in the lung of smoking-induced pulmonary arterial hypertension (PAH) rats , 2015, Journal of the renin-angiotensin-aldosterone system : JRAAS.
[3] K. Shi,et al. Effects of angiotensin II intervention on MMP-2, MMP-9, TIMP-1, and collagen expression in rats with pulmonary hypertension. , 2015, Genetics and molecular research : GMR.
[4] F. Pereira,et al. Effects of captopril on cardiovascular reflexes and respiratory mechanisms in rats submitted to monocrotaline-induced pulmonary arterial hypertension. , 2015, Pulmonary pharmacology & therapeutics.
[5] H. Tsuchiya,et al. A novel ACE2 activator reduces monocrotaline-induced pulmonary hypertension by suppressing the JAK/STAT and TGF-β cascades with restored caveolin-1 expression , 2015, Experimental lung research.
[6] Jose Luis Zamorano,et al. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS) , 2014 .
[7] Adam Torbicki,et al. Management of venous thrombo-embolism: an update. , 2014, European heart journal.
[8] N. Stergiopulos,et al. The Angiotensin-Converting Enzyme 2/Angiotensin-(1–7)/Mas receptor axis: A potential target for treating thrombotic diseases , 2012, Thrombosis and Haemostasis.
[9] I. Vlachos,et al. Use of the impedance threshold device improves survival rate and neurological outcome in a swine model of asphyxial cardiac arrest* , 2012, Critical care medicine.
[10] J. Tanus-Santos,et al. Losartan exerts no protective effects against acute pulmonary embolism-induced hemodynamic changes , 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.
[11] R. Lutter,et al. Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin‐(1–7) or an angiotensin II receptor antagonist , 2011, The Journal of pathology.
[12] J. Kline,et al. Effects of angiotensin (1-7) upon right ventricular function in experimental rat pulmonary embolism. , 2011, Histology and histopathology.
[13] K. Metze,et al. Near-fatal pulmonary embolism in an experimental model: hemodynamic, gasometric and capnographic variables. , 2011, Revista brasileira de cirurgia cardiovascular : orgao oficial da Sociedade Brasileira de Cirurgia Cardiovascular.
[14] Jennifer A. Johnson,et al. ACE2 Improves Right Ventricular Function in a Pressure Overload Model , 2011, PloS one.
[15] A. Molteni,et al. Mitigating effects of captopril and losartan on lung histopathology in a rat model of fat embolism. , 2011, The Journal of trauma.
[16] J. Zwanenburg,et al. Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling. , 2008, Journal of the American College of Cardiology.
[17] N. Polissar,et al. Endothelin receptor blockade does not improve hypoxemia following acute pulmonary thromboembolism. , 2007, Journal of applied physiology.
[18] S. Kase,et al. Captopril suppresses inflammation in endotoxin-induced uveitis in rats. , 2006, Experimental eye research.
[19] M. Hlastala,et al. Spatial pattern of ventilation-perfusion mismatch following acute pulmonary thromboembolism in pigs. , 2005, Journal of applied physiology.
[20] R. A. Santos,et al. Cardiovascular actions of angiotensin-(1-7). , 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[21] A. Amann,et al. The Effects of Nifedipine on Ventricular Fibrillation Mean Frequency in a Porcine Model of Prolonged Cardiopulmonary Resuscitation , 2003, Anesthesia and analgesia.
[22] J. Kline,et al. Biventricular cardiac dysfunction after acute massive pulmonary embolism in the rat. , 2001, Journal of applied physiology.
[23] Y. Smulders,et al. Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. , 2000, Cardiovascular research.
[24] W M O'Fallon,et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. , 2000, Archives of internal medicine.
[25] M. Daemen,et al. Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension. , 1998, American journal of respiratory and critical care medicine.
[26] J. W. Henry,et al. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. , 1995, Chest.
[27] D. Diz,et al. Cardiovascular actions of angiotensin(1–7) , 1993, Peptides.
[28] J. Herget,et al. ROS scavenger decreases basal perfusion pressure, vasoconstriction and NO synthase activity in pulmonary circulation during pulmonary microembolism. , 2015, Physiological research.
[29] Chunsheng Li,et al. Thrombolysis after initially unsuccessful cardiopulmonary resuscitation in presumed pulmonary embolism. , 2015, The American journal of emergency medicine.
[30] P. Neužil,et al. Pig model of pulmonary embolism: where is the hemodynamic break point? , 2013, Physiological research.